Convergent Therapeutics Appoints Michael Rossi to its Board of Directors
Rossi Brings Decades of Leadership as Convergent Advances its Alpha-based Radioantibody for Prostate Cancer to Late-Stage Clinical Development Convergent Therapeutics Inc., a clinical-stage biotechnology company...